Microbial Resistance of Rifaximin in Hepatic Encephalopathy

Clinical trial NCT04736836 · COMPLETED

Trial details

NCT number: NCT04736836
Sponsor: National Hepatology & Tropical Medicine Research Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatic Encephalopathy

Start date: 2015-01-01
Primary completion: 2018-12-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.